Literature DB >> 26845136

8-bromo-7-methoxychrysin Reversed M2 Polarization of Tumor-associated Macrophages Induced by Liver Cancer Stem-like Cells.

Shuwen Sun, Yinghong Cui, Kaiqun Ren, Meifang Quan, Zhenwei Song, Hui Zou, Duo Li, Yu Zheng, Jianguo Cao1.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is related to chronic liver inflammation. M2 polarization of tumor-associated macrophages (TAMs) in the tumor microenvironment promotes liver cancer stem-like cell (LCSLC) self-renewal capability and carcinogenicity. Therefore, reversing M2 polarization of TAMs could be an effective approach to cure HCC.
OBJECTIVE: To evaluate whether 8-bromo-7-methoxychrysin (BrMC) has an effect on M2 polarization of TAMs.
METHOD: LCSLC and conditional medium were obtained by sphere forming assay. Identification of LCSLC were analyzed by sphere forming, wound-healing and invasion assay. TAM and effects of BrMC on it were validated by immunofluorescence staining, ELISA and griess assay. Expressions of cancer stem cell and macrophage marker were analyzed by western blotting.
RESULTS: Our results showed that BrMC significantly suppressed the expression of the M2 macrophage marker CD163. Furthermore, BrMC influenced the secretion profile of cytokines of TAMs. Mechanistically, BrMC reversed M2 polarization of TAMs due to inhibition of NF-κB activation.
CONCLUSION: BrMC may be a potentially novel flavonoid agent that can be applied for disrupting the interaction of LCSLCs and TAMs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 26845136     DOI: 10.2174/1871520616666160204112556

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  6 in total

1.  Blocking the Notch signal transduction pathway promotes tumor growth in breast cancer by promoting the expression of suppressible inflammatory factors.

Authors:  Shuguang Ren; Yueyang Hu; Yingchao Ju; Yang Sang; Jianhua Wu; Yiming Ge; Beichen Liu; Xiaohan Zhao; Xiangmei Zhang; Yunjiang Liu
Journal:  Ann Transl Med       Date:  2022-03

Review 2.  Functional macrophages and gastrointestinal disorders.

Authors:  Yue-Hong Liu; Yue Ding; Chen-Chen Gao; Li-Sheng Li; Yue-Xiu Wang; Jing-Dong Xu
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

Review 3.  Macrophages and hepatocellular carcinoma.

Authors:  Zhiqiang Tian; Xiaojuan Hou; Wenting Liu; Zhipeng Han; Lixin Wei
Journal:  Cell Biosci       Date:  2019-09-26       Impact factor: 7.133

4.  8-bromo-7-methoxychrysin targets NF-κB and FoxM1 to inhibit lung cancer stem cells induced by pro-inflammatory factors.

Authors:  Qing Yuan; Min Wen; Chang Xu; A Chen; Ye-Bei Qiu; Jian-Guo Cao; Jian-Song Zhang; Zhen-Wei Song
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

Review 5.  The immune landscape of hepatocellular carcinoma-where we are?

Authors:  Maciej Gryziak; Krzysztof Wozniak; Leszek Kraj; Letycja Rog; Rafal Stec
Journal:  Oncol Lett       Date:  2022-09-27       Impact factor: 3.111

Review 6.  Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.

Authors:  Peter Kubatka; Alena Mazurakova; Marek Samec; Lenka Koklesova; Kevin Zhai; Raghad Al-Ishaq; Karol Kajo; Kamil Biringer; Desanka Vybohova; Aranka Brockmueller; Martin Pec; Mehdi Shakibaei; Frank A Giordano; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  EPMA J       Date:  2021-10-06       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.